Received Sep 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC13 | PNEUMO (PREVNAR13) | PFIZER\WYETH | UNK | — | OT |
| PNC20 | PNEUMO (PREVNAR20) | PFIZER\WYETH | UNK | — | OT |
| PPV | PNEUMO (PNEUMOVAX) | MERCK & CO. INC. | UNK | — | OT |
she had received multiple pneumococcal vaccines, potentially too close together; No adverse event; This spontaneous report was received from the 75-year-old female patient, concerning herself. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On unknown date, the patient was vaccinated with Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX 23), 0.5 mL administered by Unknown route (lot # and expiration date were not reported) for prophylaxis, with PREVNAR 13 and with PREVNAR 20 administered by Unknown route (indication, expiration date, and lot # were not reported). The patient had received multiple pneumococcal vaccines such as Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX 23), PREVNAR 13 and PREVNAR 20, potentially too close together (Inappropriate schedule of product administration). No adverse event was reported. Batch/Lot number is being requested and will be submitted if received.